Xray Launches AI-Powered, Human-Guided Test Capabilities with Sembi IQ
In a recent article in The AI Journal, Xray introduced Jira-native AI for test case and model generation powered by Sembi IQ that keeps humans in the loop for review and governance. The coverage highlights enterprise controls, data privacy, and faster paths from requirement to release.
How Swift’s blockchain could boost bank stablecoins
Stablecoins are edging closer to mainstream banking rails as Swift builds a shared-ledger network with major banks to enable tokenized settlements. In a recent American Banker article, the network’s design around ISO 20022 data standards and broad bank participation is framed as a way to bring programmability and always-on settlement into traditional finance.
Clinical Intelligence Company Cohere Health Announces Acquisition of ZignaAI
Cohere Health is expanding its clinical intelligence capabilities with the acquisition of ZignaAI and the launch of a Payment Integrity suite built for near real-time clinical and coding validation. A recent Forbes article highlights how the move aims to bring more transparency to claims oversight and shift reviews upstream to reduce friction between payers and providers.
Motive, Fleetio Expand Partnership
To help fleets cut manual work around fuel and maintenance, Motive and Fleetio have deepened their integration to centralize fuel, maintenance, and telematics data. In coverage from Transport Topics, the companies point to new two-way syncs that streamline compliance, sharpen visibility, and give operators a clearer view of fuel and service spend.
Collaborative Innovation in CDMOs: Dave Miller, PhD, on Early Engagement, IP Strategy, and Advanced Formulation
AustinPx CSO Dave Miller, PhD, uses a recent BioPharm International conversation to spotlight earlier sponsor engagement, lifecycle-minded IP strategy, and high-science platforms like KinetiSol as pillars of “true co-development.” He positions modern CDMO partnerships as extensions of the sponsor team, from early design decisions through commercialization.
401(k) plans rife with overpriced, underperforming investment options, study finds
In a recent Pensions & Investments article, a new analysis highlights widespread “clunker” funds in corporate 401(k)s—costly options that trail cheaper alternatives and erode participant outcomes. The coverage notes that the review spanned tens of thousands of plans and urges sponsors to replace underperformers with lower-fee choices.
Expert tips to choose the right CDMO for your biotech company
Elizabeth Hickman, CEO of AustinPx, recently shared her take on what really matters when choosing a CDMO partner. In this interview, she stresses that technical capability is a must, but it must go beyond what's written in a brochure. The CDMO’s real-world experience, systems, and ability to keep up with the fast pace of development should be the key differentiator.
AI can dramatically improve our approach to primary care and chronic disease management
In a value-based care environment, aligning financial and clinical strategies is essential for success. In a recent article, Rajiv Mahale, Chief Product and Business Development Officer at Cedar Gate Technologies, shares how integrated data intelligence and performance management tools are helping healthcare organizations manage risk, improve outcomes, and boost profitability.
AI can enable fake job applicants. How do recruiters protect themselves?
As AI tools become common in the job search process, a troubling trend is emerging: some candidates are using the technology to create fake resumes and forged credentials. In a recent interview, RJ Frasca, Vice President at Shield Screening, highlights how AI can now serve a dual role, both aiding job seekers and helping recruiters spot fraudulent applications.








